-
公开(公告)号：US07794744B2
公开(公告)日：2010-09-14
申请号：US10257208
申请日：2001-04-03
申请人： Olivier Ballevre , Julio Boza , Denis Breuille , Paul-André Finot , Véronique Jaussan , Claudia Roessle , Thomas Schweizer
发明人： Olivier Ballevre , Julio Boza , Denis Breuille , Paul-André Finot , Véronique Jaussan , Claudia Roessle , Thomas Schweizer
IPC分类号： A61K47/00
CPC分类号： A61K45/06 , A23L33/135 , A23L33/15 , A23L33/16 , A23L33/175 , A23L33/30 , A23L33/40 , A23V2002/00 , A23Y2220/63 , A23Y2300/00 , A23V2250/062 , A23V2250/0616 , A23V2250/0648 , A23V2250/061 , A23V2250/0642 , A23V2250/708 , A23V2250/1642 , A23V2250/1626 , A23V2250/206 , A23V2250/712 , A23V2250/211
摘要： The present invention relates to a method for preparing an enteral nutrition at the bed of a patient, which involves the use of a standard enteral solution to which is added, via a closed system, one or more compositions in module form, containing selected nutrients, adapted for a specific clinical condition. The present invention also pertains to the different modules, that are preferably in dry form and to the use thereof in the treatment and/or nourishment of a critically ill person.
摘要翻译： 本发明涉及一种在患者床上制备肠内营养的方法，其涉及使用通过封闭系统加入一种或多种包含所选营养物的模块形式的组合物的标准肠内溶液， 适应特定的临床状况。 本发明还涉及不同的模块，其优选为干燥形式，并且涉及在危重患者的治疗和/或营养中的应用。
-
公开(公告)号：US06995189B1
公开(公告)日：2006-02-07
申请号：US10070486
申请日：2000-09-07
申请人： Marco Turini , Claudia Roessle , Denis Breuille , Gayle Crozier-Willi , Paul André Finot , Myriam Richelle , Guy Dutot
发明人： Marco Turini , Claudia Roessle , Denis Breuille , Gayle Crozier-Willi , Paul André Finot , Myriam Richelle , Guy Dutot
IPC分类号： A61K31/00 , A61K31/20 , A61K31/201 , A61K31/202 , A61K31/225
摘要： A composition for use as a medicament or nutritional product is described which comprises at least one lipid wherein the lipid provides greater tan 35% total energy of the composition. A prefered embodiment comprises a n-6/n-3 fatty acid ratio of about 2/1 to 7/1. In addition, a method of preparing the composition; use of the composition in the manufacture of a medicament or nutritional product; and a method of treatment or prevention of sepsis or inflammatory shock which comprises administering an effective amount of the composition are described.
摘要翻译： 描述了用作药物或营养产品的组合物，其包含至少一种脂质，其中所述脂质提供组合物的更大的35％总能量。 优选的实施方案包括约2/1至7/1的n-6 / n-3脂肪酸比。 另外，制备组合物的方法; 在制备药物或营养产品中使用该组合物; 以及治疗或预防败血症或炎性休克的方法，其包括施用有效量的组合物。
-
公开(公告)号：US07691906B2
公开(公告)日：2010-04-06
申请号：US11204885
申请日：2005-08-16
申请人： Marco Turini , Claudia Roessle , Denis Breuille , Gayle Crozier-Willi , Paul André Finot , Myriam Richelle , Guy Dutot , Christiane Obled
发明人： Marco Turini , Claudia Roessle , Denis Breuille , Gayle Crozier-Willi , Paul André Finot , Myriam Richelle , Guy Dutot , Christiane Obled
IPC分类号： A61K31/00 , A61K31/20 , A61K31/201 , A61K31/202 , A61K31/225 , A61K31/70 , A61K38/00 , A61P3/00
摘要： A composition for use as a medicament, functional food or nutritional product is described which comprises at least one lipid wherein the lipid provides greater than 35% total energy of the composition. A preferred embodiment comprises a n-6/n-3 fatty acid ratio of about 2/1 to 7/1. In addition, a method of preparing the composition; use of the composition in the manufacture of a medicament, functional food or nutritional product; and a method of treatment or treatment or prevention of sepsis or inflammatory shock which comprises administering an effective amount of the composition are described.
摘要翻译： 描述了用作药物，功能性食品或营养产品的组合物，其包含至少一种脂质，其中所述脂质提供组合物的总能量的35％以上。 优选的实施方案包括约2/1至7/1的n-6 / n-3脂肪酸比。 另外，制备组合物的方法; 在制备药物，功能性食品或营养产品中使用该组合物; 以及治疗或治疗或预防败血症或炎性休克的方法，其包括施用有效量的组合物。
-
公开(公告)号：US20120035234A1
公开(公告)日：2012-02-09
申请号：US13275996
申请日：2011-10-18
IPC分类号： A61K31/198 , A61P1/00 , A61K31/4172 , A61K31/401 , A61K31/405
CPC分类号： A61K31/195 , A23L33/175 , A23L33/40 , A61K31/415 , A61K31/404 , A61K31/40 , A61K2300/00
摘要： A composition is described that can be used in prevention or treatment of patients having impaired gastro-intestinal tract function. The composition comprises free amino acids including about 9.0% to about 17.0% glutamic acid. Methods of treatment of impaired gastro-intestinal tract function are described.
摘要翻译： 描述了可用于预防或治疗胃肠道功能受损患者的组合物。 组合物包含游离氨基酸，包括约9.0％至约17.0％的谷氨酸。 描述了治疗胃肠道功能受损的方法。
-
公开(公告)号：US08067471B2
公开(公告)日：2011-11-29
申请号：US11380841
申请日：2006-04-28
IPC分类号： A61K31/195
CPC分类号： A61K31/195 , A23L33/175 , A23L33/40 , A61K31/415 , A61K31/404 , A61K31/40 , A61K2300/00
摘要： A composition is described that can be used in prevention or treatment of patients having impaired gastro-intestinal tract function. The composition comprises free amino acids including about 9.0% to about 17.0% glutamic acid. Methods of treatment of impaired gastro-intestinal tract function are described.
摘要翻译： 描述了可用于预防或治疗胃肠道功能受损患者的组合物。 组合物包含游离氨基酸，包括约9.0％至约17.0％的谷氨酸。 描述了治疗胃肠道功能受损的方法。
-
-
-
-
搜索结果
5 条记录 (耗时 0.011 秒)
